The relationship between focal erosions and generalized osteoporosis in postmenopausal women with rheumatoid arthritis

Arthritis and Rheumatism

Volumn 60, Issue 6, 2009, Pages 1624-1631

  Solomon, Daniel H ^a   Finkelstein, Joel S ^b   Shadick, Nancy ^a   LeBoff, Meryl S ^a   Winalski, Carl S ^c   Stedman, Margaret ^a   Glass, Roberta ^a   Brookhart, M Alan ^a   Weinblatt, Michael E ^a   Gravallese, Ellen M ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; RHEUMATOID FACTOR;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BONE DENSITY; BONE EROSION; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DISEASE DURATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HAND RADIOGRAPHY; HEALTH ASSESSMENT QUESTIONNAIRE; HIP; HUMAN; LINEAR REGRESSION ANALYSIS; LUMBAR SPINE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SHARP METHOD; TECHNIQUE;

AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BONE DENSITY; BONE DISEASES; COHORT STUDIES; FEMALE; FRACTURES, BONE; HAND; HEALTH SURVEYS; HIP JOINT; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPINE; TREATMENT OUTCOME;

EID: 66449104060     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24551     Document Type: Article

References (29)

1. Rasch EK, Hirsch R, Paulose-Ram R, Hochberg MC. Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification. Arthritis Rheum 2003;48:917-926 (Pubitemid 36418233)
2. Gabriel SE. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 2001;27:269-281 (Pubitemid 32488705)
3. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001;358:903-911 (Pubitemid 32900579)
4. Van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 2006;54:3104-3112 (Pubitemid 44622079)
5. Walsh NC, Gravallese EM. Bone loss in inflammatory arthritis: mechanisms and treatment strategies. Curr Opin Rheumatol 2004;16:419-427 (Pubitemid 38803144)
6. Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 1998;152:943-951 (Pubitemid 28173356)
7. Haugeberg G, Lodder MC, Lems WF, Uhlig T, Orstavik RE, Dijkmans BA, et al. Hand cortical bone mass and its associations with radiographic joint damage and fractures in 50-70 year old female patients with rheumatoid arthritis: cross sectional Oslo-Truro-Amsterdam (OSTRA) collaborative study. Ann Rheum Dis 2004;63:1331-1334 (Pubitemid 39273517)
8. Redlich K, Gortz B, Hayer S, Zwerina J, Doerr N, Kostenuik P, et al. Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis. Am J Pathol 2004;164:543-555 (Pubitemid 38364670)
9. Solomon DH, Stedman M, Licari A, Weinblatt ME, Maher N, Shadick N. Agreement between patient report and medical record review for medications used for rheumatoid arthritis: the accuracy of self-reported medication information in patient registries. Arthritis Rheum 2007;57:234-239 (Pubitemid 47164084)
10. Sharp JT, Young DY, Bluhm GB, Brook A, Brower AC, Corbett M, et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 1985;28:1326-1335
11. Boini S, Guillemin F. Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages. Ann Rheum Dis 2001;60:817-827 (Pubitemid 32778171)
12. Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003;42:244-257 (Pubitemid 36305610)
13. Katz JN, Larson MG, Phillips CB, Fossel AH, Liang MH. Comparative measurement sensitivity of short and longer health status instruments. Med Care 1992;30:917-925
14. Kaufmann J, Kielstein V, Kilian S, Stein G, Hein G. Relation between body mass index and radiological progression in patients with rheumatoid arthritis. J Rheumatol 2003;30:2350-2355 (Pubitemid 37413892)
15. Garnero P, Landewe R, Boers M, Verhoeven A, van der Linden S, Christgau S, et al. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum 2002;46:2847-2856 (Pubitemid 35315875)
16. Jensen T, Hansen M, Jensen KE, Podenphant J, Hansen TM, Hyldstrup L. Comparison of dual X-ray absorptiometry (DXA), digital X-ray radiogrammetry (DXR), and conventional radiographs in the evaluation of osteoporosis and bone erosions in patients with rheumatoid arthritis. Scand J Rheumatol 2005;34:27-33. (Pubitemid 40445055)
17. Stewart A, Mackenzie LM, Black AJ, Reid DM. Predicting erosive disease in rheumatoid arthritis. A longitudinal study of changes in bone density using digital X-ray radiogrammetry: a pilot study. Rheumatology (Oxford) 2004;43:1561-1564
18. Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol 1977;18:481-491 (Pubitemid 8198049)
19. Forslind K, Keller C, Svensson B, Hafstrom I, Group BS. Reduced bone mineral density in early rheumatoid arthritis is associated with radiological joint damage at baseline and after 2 years in women. J Rheumatol 2003;30:2590-2596 (Pubitemid 37549335)
20. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study). Arthritis Rheum 2005;52:3381-3390 (Pubitemid 41612204)
21. Guler-Yuksel M, Allaart CF, Goekoop-Ruiterman YP, de Vries- Bouwstra JK, van Groenendael JH, Mallee C, et al. Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis. Ann Rheum Dis 2009;68:330-336
22. Matsui T, Kuga Y, Kaneko A, Nishino J, Eto Y, Chiba N, et al. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann Rheum Dis 2007;66:1221-1226 (Pubitemid 47309741)
23. Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005;7:R796-806.
24. Patel S, Farragher T, Symmons D. Reply to letter by Lippi et al commenting on the relationship between serum vitamin D levels and levels of inflammation markers [letter]. Arthritis Rheum 2008;58:1882.
25. Cutolo M, Otsa K, Uprus M, Paolino S, Seriolo B. Vitamin D in rheumatoid arthritis. Autoimmun Rev 2007;7:59-64. (Pubitemid 47633393)
26. Lange U, Teichmann J, Muller-Ladner U, Strunk J. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-α antibody: a prospective open-label pilot study. Rheumatology (Oxford) 2005;44:1546-1548 (Pubitemid 41742473)
27. Guler-Yuskel M, Bijsterbosch J, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Hulsmans HM, de Beus WM, et al. Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis. Ann Rheum Dis 2008;67:823-828
28. McClung MR, Lewiecki EM, Cohen SB, Bolognese MA, Woodsen GC, Moffett AH, et al. Denosumab in postmenopausal women with low bone mineral density. N Engl J Med 2006;354:821-831 (Pubitemid 43290920)
29. Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT, et al, and the Denosumab Rheumatoid Arthritis Study Group. Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum 2008;58:1299-1309